Journal article
Left atrial appendage occlusion.
- Nietlispach F University Heart Center, University Hospital Zurich, Zurich, Switzerland.
- Moarof I
- Taramasso M
- Maisano F
- Meier B
- 2017-09-25
Published in:
- EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. - 2017
Adult
Aged
Aged, 80 and over
Anticoagulants
Atrial Appendage
Atrial Fibrillation
Female
Hemorrhage
Humans
Male
Middle Aged
Risk Factors
Septal Occluder Device
Stroke
Treatment Outcome
English
Left atrial appendage occlusion (LAAO) is a first-line therapy for stroke prevention in patients suffering from atrial fibrillation (AF). While patients at high risk for bleeding or patients with previous bleeding have the highest relative risk reduction from LAAO, it is the younger patients with a high lifetime bleeding risk who benefit from the highest absolute risk reduction after LAAO. Therefore, LAAO should be discussed with every AF patient, as an alternative to lifelong oral anticoagulation. The patient needs to be informed about the risks and benefits of each treatment strategy in order to take an informed treatment decision.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.4244/EIJ-D-17-00412
- PMID 28942389
- Persistent URL
- https://sonar.ch/global/documents/21446
Statistics
Document views: 29
File downloads: